Cite
HARVARD Citation
Sanganalmath, P. et al. (2018). Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. Clinical oncology. 30 (3), pp. 144-150. [Online].